These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8665695)

  • 1. Simple, sensitive microplate IRMAs for intact and des-31,32-proinsulin compared with HPLC and cellulose IRMAs.
    Mohamed-Ali V; Nagi DK; Yudkin JS
    Clin Chem; 1996 Jun; 42(6 Pt 1):977-9. PubMed ID: 8665695
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoradiometric assay of human intact proinsulin applied to patients with type 2 diabetes, impaired glucose tolerance, and hyperandrogenism.
    Chevenne D; Ruiz J; Lohmann L; Laudat A; Leblanc H; Gray IP; Passa P; Porquet D
    Clin Chem; 1994 May; 40(5):754-7. PubMed ID: 8174247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.
    Kahn SE; Halban PA
    Diabetes; 1997 Nov; 46(11):1725-32. PubMed ID: 9356018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinsulin conversion intermediates: a possible source of confusion.
    Halban PA
    Diabetologia; 1991 Mar; 34(3):202-3. PubMed ID: 1884895
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of proinsulin and intermediates. Validation of immunoassay methods by high-performance liquid chromatography.
    Ostrega D; Polonsky K; Nagi D; Yudkin J; Cox LJ; Clark PM; Hales CN
    Diabetes; 1995 Apr; 44(4):437-40. PubMed ID: 7698513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of specific immunoradiometric assay to determine preterm neonatal insulin-glucose relations.
    Hawdon JM; Hubbard M; Hales CN; Clark PM
    Arch Dis Child Fetal Neonatal Ed; 1995 Nov; 73(3):F166-9. PubMed ID: 8535874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proinsulin immunoreactivity in identical twins discordant for noninsulin-dependent diabetes mellitus.
    Røder ME; Vaag A; Hartling SG; Dinesen B; Lanng S; Beck-Nielsen H; Binder C
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2359-63. PubMed ID: 7629230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rapid, sensitive and versatile two-site immunoradiometric assay for insulin.
    Guest PC; Lowing C; Arden SD; Gray IP; Hutton JC
    Mol Cell Endocrinol; 1989 Dec; 67(2-3):173-8. PubMed ID: 2693160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin-like molecules and plasminogen activator inhibitor type 1 (PAI-1) activity in diabetic and non-diabetic subjects with and without myocardial infarction.
    Gray RP; Panahloo A; Mohamed-Ali V; Patterson DL; Yudkin JS
    Atherosclerosis; 1997 Apr; 130(1-2):171-8. PubMed ID: 9126661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation and quantitation of serum proinsulin and proinsulin intermediates in humans.
    Linde S; Røder ME; Hartling SG; Binder C; Welinder BS
    J Chromatogr; 1991 Jul; 548(1-2):371-80. PubMed ID: 1939435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting proinsulin concentrations predict the development of type 2 diabetes.
    Wareham NJ; Byrne CD; Williams R; Day NE; Hales CN
    Diabetes Care; 1999 Feb; 22(2):262-70. PubMed ID: 10333943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study.
    Zethelius B; Byberg L; Hales CN; Lithell H; Berne C
    Diabetologia; 2003 Jan; 46(1):20-6. PubMed ID: 12637978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-resolved immunofluorometric assay for quantifying proinsulin in serum.
    Engling US; Missler U; Kerner W
    Clin Chem; 1995 Jun; 41(6 Pt 1):942-3. PubMed ID: 7768017
    [No Abstract]   [Full Text] [Related]  

  • 14. Amplified enzyme-linked immunoassay of human proinsulin in serum (detection limit: 0.1 pmol/L).
    Dhahir FJ; Cook DB; Self CH
    Clin Chem; 1992 Feb; 38(2):227-32. PubMed ID: 1541005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and use in immunoradiometric assay of monoclonal antibodies directed against human proinsulin.
    Gray IP; Siddle K; Frank BH; Hales CN
    Diabetes; 1987 Jun; 36(6):684-8. PubMed ID: 2436963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies.
    Kjems LL; Røder ME; Dinesen B; Hartling SG; Jørgensen PN; Binder C
    Clin Chem; 1993 Oct; 39(10):2146-50. PubMed ID: 8403400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin.
    Pfützner A; Pfützner AH; Kann PH; Burgard G
    J Diabetes Sci Technol; 2017 Mar; 11(2):278-283. PubMed ID: 27559030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
    Pfützner A; Pfützner AH; Larbig M; Forst T
    Diabetes Technol Ther; 2004 Jun; 6(3):405-12. PubMed ID: 15198846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical validation of renin monoclonal antibody-based sandwich assays of renin and prorenin, and use of renin inhibitor to enhance prorenin immunoreactivity.
    Derkx FH; de Bruin RJ; van Gool JM; van den Hoek MJ; Beerendonk CC; Rosmalen F; Haima P; Schalekamp MA
    Clin Chem; 1996 Jul; 42(7):1051-63. PubMed ID: 8674188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.